SBFM Sunshine Biopharma, Inc.
-
Sunshine Biopharma Reported Earnings
Thursday, August 13, 2026 · 12:00 AM ET
Sunshine Biopharma (SBFM) reported a loss of $1.15 per share on revenue of $9.26 million for the second quarter ended June 2026. . Revenue fell 1.55% compared to the same quarter a year ago.
Sunshine Biopharma Inc. is a pharmaceutical company. It focused on the research, development and commercialization of oncology and antiviral drugs. Sunshine Biopharma Inc. is based in MONTREAL.
Earnings Whisper Grade
—
Power Rating—
Reported Earnings
($1.15)
Earnings Whisper®
—
Consensus Estimate
—
Earnings Surprise
Earnings Growth
Reported Revenue
$9.26M
Revenue Estimate
—
Revenue Surprise
Revenue Growth